Usefulness of intracoronary therapy with progenitor cells in patients with dilated cardiomyopathy: Bridge or alternative to heart transplantation?;Utilidad de la terapia intracoronaria con células progenitoras en pacientes con miocardiopatía dilatada: ¿Puente o alternativa al trasplante cardiaco?

Anales de Pediatria

Volumn 74, Issue 4, 2011, Pages 218-225

  Rivas, J ^a   Menendez J J ^a   Arrieta, R ^a   Alves, J ^a   Romero, M P ^a   Garcia Guereta L ^a   Alvarez Doforno R ^a   Parron M ^a   Gonzalez A ^a   Ruza, F ^a   Gutierrez Larraya F ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

Dilated cardiomyopathy; Heart failure; Intracoronary therapy; Progenitor cells

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; CD34 ANTIGEN; GRANULOCYTE COLONY STIMULATING FACTOR; INOTROPIC AGENT;

ANTIGEN PRESENTING CELL; ARTICLE; ARTIFICIAL VENTILATION; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BODY WEIGHT; CASE REPORT; CD34 SELECTION; CLINICAL EVALUATION; CONGESTIVE CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FOLLOW UP; HEART DILATATION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART TRANSPLANTATION; HUMAN; HUMAN CELL; INFANT; INTRACORONARY INFUSION; LEUKAPHERESIS; MALE; PROTEIN BLOOD LEVEL; SYSTOLIC DYSFUNCTION;

CARDIOMYOPATHY, DILATED; CORONARY VESSELS; HEART FAILURE; HEART TRANSPLANTATION; HUMANS; INFANT; MALE; SEVERITY OF ILLNESS INDEX; STEM CELL TRANSPLANTATION;

EID: 79953722799     PISSN: 16954033     EISSN: 16959531     Source Type: Journal    
DOI: 10.1016/j.anpedi.2011.02.013     Document Type: Article

References (34)

1. Towbin JA, Lowe AM, Colan SD, Sleeper LA, Orav EJ, Clunie S, et al. Incidence, causes, and outcomes of dilated cardiomyopathy in children. JAMA. 2006;296:1867-76. (Pubitemid 44596196)
2. Wilkinson JD, Landy DC, Colan SD, Towbin JA, Sleeper LA, Orav EJ, et al. The pediatric cardiomyopathy registry and heart failure: key results from the first 15 years. Heart Fail Clin. 2010;6:401-13.
3. Nugent AW, Daubeney PE, Chondros P. The epidemiology of childhood cardiomyopathy in Australia. N Engl J Med. 2003;348:1639-46. (Pubitemid 36459469)
4. Lipshultz SE, Sleeper LA, Towbin JA, Lowe AM, Orav EJ, Cox GF, et al. The incidence of pediatric cardiomyopathy in two regions of the United States. N Engl J Med. 2003;348:1647-55. (Pubitemid 36459470)
5. Schachinger V, Erbs S, Elsasser A, Haberbosch W, Hambrecht R, Hölschermann H, et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med. 2006;355:1210-21. (Pubitemid 44427445)
6. Assmus B, Schächinger V, Teupe C, Britten M, Lehmann R, Döbert N, et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation. 2002;106:3009-17. (Pubitemid 35440281)
7. Fernández-Avilés F, San Román JA, García-Frade J, Fernández ME, Peñarrubia MJ, de la Fuente L, et al. Experimental and clinical regenerative capability of human bone marrow cells after myocardial infarction. Circ Res. 2004;95:742-8.
8. Suárez de Lezo J, Herrera C, Romero MA, Pan M, Jiménez R, Carmona D, et al. Functional recovery following intra-coronary infusion of autologous mononuclear bone marrow cells in patients with chronic anterior myocardial infarction and severely depressed ventricular function. Rev Esp Cardiol. 2010;63:1127-35.
9. Yousef M, Schannwell CM, Köstering M, Zeus T, Brehm M, Strauer BE. The BALANCE Study: clinical benefit and long-term outcome after intracoronary autologous bone marrow cell transplantation in patients with acute myocardial infarction. J Am Coll Cardiol. 2009;53:2262-9.
10. Wollert KC, Meyer GP, Lotz J, Pirr J, Rager U, Lippolt P, et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: The BOOST randomised controlled clinical trial. Lancet. 2004;364:141-8. (Pubitemid 38891685)
11. Lunde K, Solheim S, Aakhus S, Arnesen H, Abdelnoor M, Egeland T, et al. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med. 2006;355:1199-209. (Pubitemid 44427444)
12. Abdel-Latif A, Bolli R, Tleyjeh IM, Montori VM, Perin EC, Hornung CA, et al. Adult bone marrow-derived cells for cardiac repair: A systematic review and meta-analysis. Arch Intern Med. 2007;167:989-97. (Pubitemid 46835786)
13. Olguntürk R, Kula S, Sucak GT, Ozdoǧan ME, Erer D, Saygili A. Peripheric stem cell transplantation in children with dilated cardiomyopathy: preliminary report of first two cases. Pediatr Transplant. 2010;14:257-60.
14. Rupp S, Bauer J, Tonn T, Schächinger V, Dimmeler S, Zeiher AM, et al. Intracoronary administration of autologous bone marrow-derived progenitor cells in a critically ill two-yr-old child with dilated cardiomyopathy. Pediatr Transplantation. 2009;13:620-3.
15. Suárez de Lezo J, Pan M, Herrera C. Combined percutaneous revascularization and cell therapy after failed repair of anomalous origin of left coronary artery from pulmonary artery. Catheter Cardiovasc Interv. 2009;73:833-7.
16. Rupp S, Séller AM, Dimmeler S, Tonn T, Bauer J, Jux C, et al. A regenerative strategy for heart failure in hypoplastic left heart syndrome: Intracoronary administration of autologous bone marrow-derived progenitor cells. J Heart Lung Transplant. 2010;29:574-7.
17. Harmon WG, Sleeper LA, Cuniberti L, Messere J, Colan SD, Orav EJ, et al. Treating children with idiopathic dilated cardiomyopathy (from the Pediatric Cardiomyopathy Registry). Am J Cardiol. 2009;104:281-5.
18. Towbin JA. Cardiomyopathy and heart transplantation in children. Current Opin Cardiol. 2002;17:274-9. (Pubitemid 34553633)
19. Almond CS, Thiagarajan RR, Piercey GE, Gauvreau K, Blume ED, Bastardi HJ, et al. Waiting list mortality among children listed for heart transplantation in the United States. Circulation. 2009;119:717-27.
20. Cassidy J, Haynes S, Kirk R, Crossland D, Smith JH, Hamilton L, et al. Changing patterns of bridging to heart transplantation in children. J Heart Lung Transplant. 2009;28:249-54.
21. Potapov EV, Stiller B, Hetzer R. Ventricular assist devices in children: Current achievements and future perspectives. Pediatr Transplant. 2007;11:241-55. (Pubitemid 46570136)
22. Goldman AP, Cassidy J, de Leval M, Haynes S, Brown K, Whitmore P, et al. The waiting game: bridging to paediatric heart transplantation. Lancet. 2003;362:1967-70. (Pubitemid 37548420)
23. Levi D, Marelli D, Plunkett M, Alejos J, Bresson J, Tran J, et al. Use of assist devices and ECMO to bridge pediatric patients with cardiomyopathy to transplantation. J Heart Lung Transplant. 2002;21:760-70. (Pubitemid 34718181)
24. Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson SM, Li B, et al. Bone marrow cells regenerate infarcted myocardium. Nature. 2001;410:701-5. (Pubitemid 32290358)
25. Tse HF, Siu CW, Zhu SG, Songyan L, Zhang QY, Lai WH, et al. Paracrine effects of direct intramyocardial implantation of bone marrow derived cells to enhance neovascularization in chronic ischaemic myocardium. Eur J Heart Fail. 2007;9:747-53. (Pubitemid 47212824)
26. Kamihata H, Matsubara H, Nishiue T, Fujiyama S, Tsutsumi Y, Ozono R, et al. Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines. Circulation. 2001;104:1046-52. (Pubitemid 32803883)
27. Dimmeler S, Zeiher AM, Schneider MD. Unchain my heart: the scientific foundations of cardiac repair. J Clin Invest. 2005;115:572-83. (Pubitemid 40322227)
28. Beltrami AP, Barlucchi L, Torella D, Baker M, Limana F, Chimenti S, et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell. 2003;114:763-76.
29. Murasawa S, Shibata T, Suehiro S, Nakamori TA, Nishimura H, Sadamoto K, et al. Dose-dependent contribution of CD34- positive cell transplantation to concurrent vasculogenesis and cardiomyogenesis for functional regenerative recovery after myocardial infarction. Circulation. 2006;113:1311-25. (Pubitemid 43739453)
30. Mäkelä J, Anttila V, Ylitalo K, Takalo R, Lehtonen S, Mäkikallio T, et al. Acute homing of bone marrow-derived mononuclear cells in intramyocardial vs. intracoronary transplantation. Scand Cardiovasc J. 2009;43:366-73.
31. Srinivas G, Anversa P, Frishman WH. Cytokines and myocardial regeneration: A novel treatment option for acute myocardial infarction. Cardiol Rev. 2009;17:1-9.
32. Harada M, Qin Y, Takano H, Minamino T, Zou Y, Toko H, et al. G-CSF prevents cardiac remodelling after myocardial infarction by activating the Jak-Stat pathway in cardiomyocytes. Nature Med. 2005;11:305-11. (Pubitemid 40460559)
33. Schächinger V, Assmus B, Britten MB, Honold J, Lehmann R, Teupe C, et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: Final one-year results of the TOPCARE-AMI Trial. J Am Coll Cardiol. 2004;44:1690-9. (Pubitemid 39369805)
34. Menasché P. Current status and future prospects for cell transplantation to prevent congestive heart failure. Semin Thorac Cardiovasc Surg. 2008;20:131-7.